A Comparative Study on the Clinical Outcomes of Bipolar Radiofrequency Thermotherapy Versus Transurethral Resection of the Prostate in Storage Symptoms Associated With Benign Prostatic Obstruction
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms. Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients’ International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed. Results: While the preprocedural OAB-V8 in the RF thermotherapy group was 25.85, this score decreased to 18.12 (P<0.001) at the postprocedural 3rd month and 16.42 (P<0.001) at the postprocedural 6th month. While the preprocedural OAB-V8 score in TURP group was 23.26, it decreased to 20.17 (P<0.001) at the postprocedural 3rd month and 19.84 at the postproce dural 6th month, and there was no significant difference between the 3rd-month and 6th-month values (P=0.328). The proportion of de crease in the OAB-V8 scores was 30% at the 3rd month and 36% at the 6th month in the RF thermotherapy group, whereas it was 13% at the 3rd month and 15% at the 6th month in TURP group. Conclusions: It was determined that RF thermotherapy was 2.35 times more effective than TURP on OAB-V8 scores. In addition to its acceptable effect on Qmax, its continued effect on storage symptoms at 6 months may be a significant advantage over the TURP. As a minimally invasive method, RF thermotherapy can be offered as a suitable option for BPO patients with storage symptoms.
Abstract
Purpose: The aim of the study was to compare the results of radiofrequency (RF) thermotherapy and transurethral resection of the prostate (TURP) in patients who required benign prostatic obstruction (BPO) surgery and had storage symptoms. Methods: The results of patients who had undergone TURP and RF thermotherapy procedures between December 2019 and 2022 were compared before and after the procedure. Patients’ International Prostate Symptom Scores, maximum flow rate (Qmax), postvoiding residues, and overactive bladder validated 8 scores (OAB-V8) at 3 and 6 months were analyzed. Results: While the preprocedural OAB-V8 in the RF thermotherapy group was 25.85, this score decreased to 18.12 (P<0.001) at the postprocedural 3rd month and 16.42 (P<0.001) at the postprocedural 6th month. While the preprocedural OAB-V8 score in TURP group was 23.26, it decreased to 20.17 (P<0.001) at the postprocedural 3rd month and 19.84 at the postproce dural 6th month, and there was no significant difference between the 3rd-month and 6th-month values (P=0.328). The proportion of de crease in the OAB-V8 scores was 30% at the 3rd month and 36% at the 6th month in the RF thermotherapy group, whereas it was 13% at the 3rd month and 15% at the 6th month in TURP group. Conclusions: It was determined that RF thermotherapy was 2.35 times more effective than TURP on OAB-V8 scores. In addition to its acceptable effect on Qmax, its continued effect on storage symptoms at 6 months may be a significant advantage over the TURP. As a minimally invasive method, RF thermotherapy can be offered as a suitable option for BPO patients with storage symptoms.
참고문헌 (25)
- Pascoe J, "Modern advancements in minimally invasive surgical treatments for benign prostatic obstruction", Ther Adv Urol, 13, pp.17562872211030832~ (2021)
- Bauer SR, "Association between lower urinary tract symptoms and frailty in older men presenting for urologic care", Urology, 148, pp.230~234 (2021)
- Takahashi S, "Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia : a Japanese post-marketing study", Low Urin Tract Symptoms, 13, pp.79~87 (2021)
- Oelke M, "Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia", Eur Urol, 54, pp.419~426 (2008)
- Rutman MP, "Overactive bladder prescribing considerations : the role of polypharmacy, anticholinergic burden, and CYP2D6 Drug-Drug Interactions", Clin Drug Investig, 41, pp.293~302 (2021)
- Lerner LB, "Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia : AUA GUIDELINE PART I-ınitial workup and medical management", J Urol, 206, pp.806~817 (2021)
- Kaplan SA, "Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving a a-blockers treatment for lower urinary tract symptoms", BJU Int, 109, pp.1831~1840 (2012)
- Cho MC, "Change in storage symptoms following laser prostatectomy : comparison between photoselective vaporization of the prostate(PVP)and holmium laser enucleation of the prostate(HoLEP)", World J Urol, 33, pp.1173~1180 (2015)
- Benli E, "Can transurethral thermotherapy save elderly patients with benign prostatic obstruction and high ASA score?", Aging Male, 23, pp.1316~1320 (2020)
- Diri MA, "Bipolar prostate thermotherapy for the improvement of chronic prostatitis symptoms and ejaculation problems", Aging Male, 23, pp.1004~1008 (2020)
- Sakalis V, "Detrusor overactivity may be a prognostic factor for better response to combination therapy over monotherapy in male patients with benign prostatic enlargement and storage lower urinary tract symptoms", Int Neurourol J, 25, pp.69~76 (2021)
- Creta M, "Detrusor overactivity and underactivity : implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment", Minerva Urol Nephrol, 73, pp.59~71 (2021)
- Cho KJ, "Correlation between nitric oxide and urodynamics in men with bladder outlet obstruction", Int Neurourol J, 26, pp.15~21 (2022)
- de Nunzio C, "The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction", J Urol, 169, pp.535~539 (2003)
- Kim KS, "Efficacy of a vaporization–resection of the prostate median lobe enlargement and vaporization of the prostate lateral lobe for benign prostatic hyperplasia using a 120-W GreenLight high-performance system laser : the effect on storage symptoms", Lasers Med Sci, 30, pp.1387~1393 (2015)
- Yi QT, "Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life", BMC Urol, 19, pp.82~ (2019)
- Allameh F, "Clinical efficacy of transurethral resection of the prostate combined with oral anticholinergics or botulinum toxin-a ınjection to treat benign prostatic hyperplasia with overactive bladder : a case-control study", Clin Pharmacol, 12, pp.75~81 (2020)
- Martin Way DA, "The effect of anticholinergics for prevention of storage symptoms after prostate photovaporization", Urol J, 16, pp.598~602 (2019)
- Sipal T, "The relation between the storage symptoms before and after transurethral resection of the prostate, analysis of the risk factors and the prevention of the symptoms with solifenacin", Int Braz J Urol, 46, pp.575~584 (2020)
- Yuce A, "Bipolar radio frequency thermotherapy vs. transurethral resection of the prostate : effect on nocturia as a result of benign prostatic obstruction", Can Urol Assoc J, 16, pp.E545~E551 (2022)
- De Wıldt M, "Clinical results of microwave thermotherapy for benign prostatic hyperplasia", J Urol, 14, pp.651~656 (2000)
- Kowalik U, "Urinary retention in surgical patients", Surg Clin North Am, 96, pp.453~467 (2016)
- Brehmer M, "Denervation of periurethral prostatic tissue by transurethral microwave thermotherapy", Scand J Urol Nephrol, 34, pp.42~45 (2000)
- Liatsikos E, "Bloodless management of benign prostatic hyperplasia : medical and minimally invasive treatment options", Aging Male, 14, pp.141~149 (2011)
- Weiss JP, "Management of nocturia : the role of antidiuretic pharmacotherapy", Neurourol Urodyn, 33, pp.19~24 (2014)